Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading ->
Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading ->
Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading ->
Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading ->
The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading ->
WHO called on European countries to step up their game to curb the highly contagious COVID-19 variants that are overtaking the region, already straining overstretched health systems. Meanwhile some researchers were warning that the new virus variants could spell double trouble if the mutation first identified in South Africa, in particular, makes new vaccines just […] Continue reading ->
The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December.  “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading ->